Singe, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. Jama 315 (8): 801–10. https://doi.org/10.1001/jama.2016.0287.
Rudd, K.E., S.C. Johnson, K.M. Agesa, K.A. Shackelford, D. Tsoi, D.R. Kievlan, et al. 2020. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study [J]. Lancet (London, England) 395 (10219): 200–11. https://doi.org/10.1016/s0140-6736(19)32989-7.
Rudd, K.E., N. Kissoon, D. Limmathurotsakul, S. Bory, B. Mutahunga, C.W. Seymour, et al. 2018. The global burden of sepsis: barriers and potential solutions [J]. Critical care (London, England) 22 (1): 232. https://doi.org/10.1186/s13054-018-2157-z.
Stephen, A.H., R.L. Montoya, and A.R. Aluisio. 2020. Sepsis and septic shock in low- and middle-income countries [J]. Surgical infections 21 (7): 571–8. https://doi.org/10.1089/sur.2020.047.
Balk, R.A. 2000. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations [J]. Critical Care Clinics 16(2): 179–92. https://doi.org/10.1016/s0749-0704(05)70106-8.
Schortgen, F. 2012. Fever in sepsis [J]. Minerva anestesiologica 78 (11): 1254–1264.
Vincent, J.L. 2022. Current sepsis therapeutics [J]. EBioMedicine 86.
Evans, T. 2018. Diagnosis and management of sepsis [J]. Clinical medicine (London, England) 18 (2): 146–9. https://doi.org/10.7861/clinmedicine.18-2-146.
Gauer, R., D. Forbes, and N. Boyer. 2020. Sepsis: Diagnosis and management [J]. American family physician 101 (7): 409–418.
Mirijello, A., and A. Tosoni. 2020. On Behalf of the Internal Medicine Sepsis Study G. New strategies for treatment of sepsis [J]. Medicina (Kaunas, Lithuania) 56(10). https://doi.org/10.3390/medicina56100527.
Vincent, J.L., G. Jones, S. David, E. Olariu, and K.K. Cadwell. 2019. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis [J]. Critical care (London, England) 23 (1): 196. https://doi.org/10.1186/s13054-019-2478-6.
Evans, L., A. Rhodes, W. Alhazzani, M. Antonelli, C.M. Coopersmith, C. French, et al. 2021. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 [J]. Critical care medicine 49 (11): e1063–e143. https://doi.org/10.1097/ccm.0000000000005337.
Wu, Y., Y.M. Yao, and Z.Q. Lu. 2019. Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure [J]. Journal of molecular medicine (Berlin, Germany) 97 (4): 451–62. https://doi.org/10.1007/s00109-019-01756-2.
Article CAS PubMed Google Scholar
Font, M.D., B. Thyagarajan, and A.K. Khanna. 2020. Sepsis and septic shock - basics of diagnosis, pathophysiology and clinical decision making [J]. The Medical clinics of North America 104 (4): 573–85. https://doi.org/10.1016/j.mcna.2020.02.011.
Van Der Poll, T., M. Shankar-Hari, and W.J. Wiersinga. 2021. The immunology of sepsis [J]. Immunity 54 (11): 2450–64. https://doi.org/10.1016/j.immuni.2021.10.012.
Article CAS PubMed Google Scholar
Annesley, S.J., and P.R. Fisher. 2019. Mitochondria in health and disease [J]. Cells 8(7). https://doi.org/10.3390/cells8070680
Cherry, A.D., and C.A. Piantadosi. 2015. Regulation of mitochondrial biogenesis and its intersection with inflammatory responses [J]. Antioxidants & redox signaling 22 (12): 965–76. https://doi.org/10.1089/ars.2014.6200.
Zhang, H., Y.W. Feng, and Y.M. Yao. 2018. Potential therapy strategy: targeting mitochondrial dysfunction in sepsis [J]. Military Medical Research 5 (1): 41. https://doi.org/10.1186/s40779-018-0187-0.
Article PubMed PubMed Central Google Scholar
Zhang, C., Y. Zhao, M. Yu, J. Qin, B. Ye, and Q. Wang. 2022. Mitochondrial dysfunction and chronic liver disease [J]. Current issues in molecular biology 44 (7): 3156–65. https://doi.org/10.3390/cimb44070218.
Article CAS PubMed PubMed Central Google Scholar
Toda, C., and S. Diano. 2014. Mitochondrial UCP2 in the central regulation of metabolism [J]. Best practice & research Clinical endocrinology & metabolism 28 (5): 757–64. https://doi.org/10.1016/j.beem.2014.02.006.
Hotchkiss, R.S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy [J]. Nature reviews Immunology 13 (12): 862–74. https://doi.org/10.1038/nri3552.
Article CAS PubMed PubMed Central Google Scholar
Boomer, J.S., K. To, K.C. Chang, O. Takasu, D.F. Osborne, A.H. Walton, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure [J]. Jama 306 (23): 2594–605. https://doi.org/10.1001/jama.2011.1829.
Article CAS PubMed PubMed Central Google Scholar
Liu, D., S.Y. Huang, J.H. Sun, H.C. Zhang, Q.L. Cai, C. Gao, et al. 2022. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options [J]. Military Medical Research 9 (1): 56. https://doi.org/10.1186/s40779-022-00422-y.
Article CAS PubMed PubMed Central Google Scholar
Palsson-Mcdermott, E.M., and L.A. O’neill. 2013. The Warburg effect then and now: from cancer to inflammatory diseases [J]. BioEssays : news and reviews in molecular, cellular and developmental biology. 35(11): 965–73. https://doi.org/10.1002/bies.201300084.
Warburg, O., F. Wind, and E. Negelein. 1927. The metabolism of tumors in the body [J]. The Journal of general physiology 8 (6): 519–30. https://doi.org/10.1085/jgp.8.6.519.
Article CAS PubMed PubMed Central Google Scholar
Warburg, O. 1956. On the origin of cancer cells [J]. Science (New York, NY) 123 (3191): 309–14. https://doi.org/10.1126/science.123.3191.309.
Article ADS CAS Google Scholar
Benny, S., R. Mishra, M.K. Manojkumar, and T.P. Aneesh. 2020. From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy [J]. Medical hypotheses 144.
Bar-Or, D., M. Carrick, A. Tanner 2nd., M.J. Lieser, L.T. Rael, and E. Brody. 2018. Overcoming the Warburg effect: is it the key to survival in sepsis? [J]. Journal of critical care 43: 197–201. https://doi.org/10.1016/j.jcrc.2017.09.012.
Samudio, I., M. Fiegl, and M. Andreeff. 2009. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism [J]. Cancer research 69 (6): 2163–6. https://doi.org/10.1158/0008-5472.Can-08-3722.
Article CAS PubMed Google Scholar
Moon, J.S., S. Lee, M.A. Park, I. Siempos, M. Haslip, and P.J. Lee. et al. 2015. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis [J]. The Journal of clinical investigation 125(2): 665–80. https://doi.org/10.1172/jci78253.
Bouillaud, F. 2009. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing [J]. Biochimica et biophysica acta 1787 (5): 377–83. https://doi.org/10.1016/j.bbabio.2009.01.003.
Article CAS PubMed Google Scholar
Hass, D.T., and C.J. Barnstable. 2021. Uncoupling proteins in the mitochondrial defense against oxidative stress [J]. Progress in retinal and eye research 83.
Esteves, P., C. Pecqueur, C. Ransy, C. Esnous, V. Lenoir, F. Bouillaud, et al. 2014. Mitochondrial retrograde signaling mediated by UCP2 inhibits cancer cell proliferation and tumorigenesis [J]. Cancer research 74 (14): 3971–82. https://doi.org/10.1158/0008-5472.Can-13-3383.
Article CAS PubMed Google Scholar
Ding, Y., Y. Zheng, J. Huang, W. Peng, X. Chen, X. Kang, et al. 2019. UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury [J]. International immunopharmacology 71: 336–49. https://doi.org/10.1016/j.intimp.2019.03.043.
Article CAS PubMed Google Scholar
Rousset, S., Y. Emre, O. Join-Lambert, C. Hurtaud, D. Ricquier, and A.M. Cassard-Doulcier. 2006. The uncoupling protein 2 modulates the cytokine balance in innate immunity [J]. Cytokine 35 (3–4): 135–42. https://doi.org/10.1016/j.cyto.2006.07.012.
Article CAS PubMed Google Scholar
Tagen, M., A. Elorza, D. Kempuraj, W. Boucher, C.L. Kepley, and O.S. Shirihai. et al. 2009. Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content [J]. Journal of immunology (Baltimore, Md : 1950) 183(10): 6313–6319. https://doi.org/10.4049/jimmunol.0803422.
Emre, Y., and T. Nübel. 2010. Uncoupling protein UCP2: when mitochondrial activity meets immunity [J]. FEBS letters 584 (8): 1437–42. https://doi.org/10.1016/j.febslet.2010.03.014.
Article CAS PubMed Google Scholar
Liu, W., T. Liu, Y. Zheng, and Z. Xia. 2023. Metabolic reprogramming and its regulatory mechanism in sepsis-mediated inflammation [J]. Journal of inflammation research 16: 1195–207. https://doi.org/10.2147/jir.S403778.
Article CAS PubMed PubMed Central Google Scholar
Cheng, S.C., L.A. Joosten, and M.G. Netea. 2014. The interplay between central metabolism and innate immune responses [J]. Cytokine & growth factor reviews 25 (6): 707–13. https://doi.org/10.1016/j.cytogfr.2014.06.008.
Liu, J., G. Zhou, X. Wang, and D. Liu. 2022. Metabolic reprogramming consequences of sepsis: adaptations and contradictions [J]. Cellular and molecular life sciences : CMLS 79 (8): 456. https://doi.org/10.1007/s00018-022-04490-0.
Article CAS PubMed Google Scholar
Owen, A.M., S.P. Patel, J.D. Smith, B.K. Balasuriya, S.F. Mori, and G.S. Hawk. et al. 2019. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model [J]. eLife 8. https://doi.org/10.7554/eLife.49920.
Peng, W., J. Huang, Y. Zheng, Y. Ding, S. Li, J. Zhang, et al. 2019. UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions [J]. Molecular medicine reports 20 (5): 4459–66.
留言 (0)